vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and NICOLET BANKSHARES INC (NIC). Click either name above to swap in a different company.
NICOLET BANKSHARES INC is the larger business by last-quarter revenue ($104.0M vs $62.1M, roughly 1.7× Cytek Biosciences, Inc.). NICOLET BANKSHARES INC runs the higher net margin — 38.8% vs -70.9%, a 109.7% gap on every dollar of revenue. On growth, NICOLET BANKSHARES INC posted the faster year-over-year revenue change (12.5% vs 8.1%). NICOLET BANKSHARES INC produced more free cash flow last quarter ($149.4M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 12.5%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
CTKB vs NIC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $104.0M |
| Net Profit | $-44.1M | $40.3M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 48.3% |
| Net Margin | -70.9% | 38.8% |
| Revenue YoY | 8.1% | 12.5% |
| Net Profit YoY | -557.1% | 16.9% |
| EPS (diluted) | — | $2.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $104.0M | ||
| Q3 25 | $52.3M | $102.9M | ||
| Q2 25 | $45.6M | $95.7M | ||
| Q1 25 | $41.5M | $89.4M | ||
| Q4 24 | $57.5M | $92.4M | ||
| Q3 24 | $51.5M | $90.7M | ||
| Q2 24 | $46.6M | $85.0M | ||
| Q1 24 | $44.9M | $82.2M |
| Q4 25 | $-44.1M | $40.3M | ||
| Q3 25 | $-5.5M | $41.7M | ||
| Q2 25 | $-5.6M | $36.0M | ||
| Q1 25 | $-11.4M | $32.6M | ||
| Q4 24 | $9.6M | $34.5M | ||
| Q3 24 | $941.0K | $32.5M | ||
| Q2 24 | $-10.4M | $29.3M | ||
| Q1 24 | $-6.2M | $27.8M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 48.3% | ||
| Q3 25 | -17.6% | 50.4% | ||
| Q2 25 | -23.3% | 46.8% | ||
| Q1 25 | -36.1% | 44.9% | ||
| Q4 24 | 5.2% | 46.8% | ||
| Q3 24 | -8.2% | 45.0% | ||
| Q2 24 | -18.3% | 43.3% | ||
| Q1 24 | -23.9% | 41.8% |
| Q4 25 | -70.9% | 38.8% | ||
| Q3 25 | -10.5% | 40.6% | ||
| Q2 25 | -12.2% | 37.6% | ||
| Q1 25 | -27.5% | 36.4% | ||
| Q4 24 | 16.8% | 37.3% | ||
| Q3 24 | 1.8% | 35.8% | ||
| Q2 24 | -22.4% | 34.5% | ||
| Q1 24 | -13.8% | 33.8% |
| Q4 25 | — | $2.63 | ||
| Q3 25 | — | $2.73 | ||
| Q2 25 | — | $2.34 | ||
| Q1 25 | — | $2.08 | ||
| Q4 24 | — | $2.21 | ||
| Q3 24 | — | $2.10 | ||
| Q2 24 | — | $1.92 | ||
| Q1 24 | — | $1.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | $134.9M |
| Stockholders' EquityBook value | $341.7M | $1.3B |
| Total Assets | $461.5M | $9.2B |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | — | $134.9M | ||
| Q3 25 | — | $134.6M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | — | $156.6M | ||
| Q4 24 | — | $161.4M | ||
| Q3 24 | — | $161.2M | ||
| Q2 24 | — | $162.4M | ||
| Q1 24 | — | $162.3M |
| Q4 25 | $341.7M | $1.3B | ||
| Q3 25 | $378.6M | $1.2B | ||
| Q2 25 | $377.6M | $1.2B | ||
| Q1 25 | $379.6M | $1.2B | ||
| Q4 24 | $395.7M | $1.2B | ||
| Q3 24 | $385.5M | $1.1B | ||
| Q2 24 | $389.1M | $1.1B | ||
| Q1 24 | $392.6M | $1.1B |
| Q4 25 | $461.5M | $9.2B | ||
| Q3 25 | $494.9M | $9.0B | ||
| Q2 25 | $493.3M | $8.9B | ||
| Q1 25 | $482.6M | $9.0B | ||
| Q4 24 | $499.5M | $8.8B | ||
| Q3 24 | $491.2M | $8.6B | ||
| Q2 24 | $483.7M | $8.6B | ||
| Q1 24 | $492.1M | $8.4B |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.11× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $153.5M |
| Free Cash FlowOCF − Capex | $-1.8M | $149.4M |
| FCF MarginFCF / Revenue | -2.9% | 143.7% |
| Capex IntensityCapex / Revenue | 1.6% | 3.9% |
| Cash ConversionOCF / Net Profit | — | 3.81× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $275.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $153.5M | ||
| Q3 25 | $-3.9M | $45.9M | ||
| Q2 25 | $108.0K | $38.9M | ||
| Q1 25 | $-125.0K | $41.8M | ||
| Q4 24 | $2.0M | $133.7M | ||
| Q3 24 | $13.2M | $39.6M | ||
| Q2 24 | $6.2M | $37.3M | ||
| Q1 24 | $4.0M | $23.4M |
| Q4 25 | $-1.8M | $149.4M | ||
| Q3 25 | $-4.6M | $45.9M | ||
| Q2 25 | $-1.5M | $38.4M | ||
| Q1 25 | $-974.0K | $41.3M | ||
| Q4 24 | $1.1M | $116.8M | ||
| Q3 24 | $12.2M | $34.7M | ||
| Q2 24 | $5.2M | $34.4M | ||
| Q1 24 | $3.4M | $20.1M |
| Q4 25 | -2.9% | 143.7% | ||
| Q3 25 | -8.7% | 44.6% | ||
| Q2 25 | -3.2% | 40.1% | ||
| Q1 25 | -2.3% | 46.2% | ||
| Q4 24 | 1.9% | 126.4% | ||
| Q3 24 | 23.7% | 38.3% | ||
| Q2 24 | 11.0% | 40.5% | ||
| Q1 24 | 7.6% | 24.4% |
| Q4 25 | 1.6% | 3.9% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 2.0% | 0.5% | ||
| Q4 24 | 1.6% | 18.3% | ||
| Q3 24 | 2.0% | 5.4% | ||
| Q2 24 | 2.3% | 3.5% | ||
| Q1 24 | 1.3% | 4.0% |
| Q4 25 | — | 3.81× | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 1.08× | ||
| Q1 25 | — | 1.28× | ||
| Q4 24 | 0.21× | 3.88× | ||
| Q3 24 | 14.05× | 1.22× | ||
| Q2 24 | — | 1.28× | ||
| Q1 24 | — | 0.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
NIC
Segment breakdown not available.
